Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
중국 베이징의 3차 진료 병원에서 COVID-19 환자의 항체 반응에 대한 종단 프로파일링
Immunology
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Analysis
anti-RBD
antibody
Antibody Response
Antibody responses
antibody-based therapies
antigens
association
asymptomatic patient
asymptomatic patients
Beijing
C-reactive protein
caused
changed
changes in
China
complement
contribute
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
death
Diagnosis
diagnostic
disease onset
elicit
global pandemic
humoral immune response
IgM and IgG
indicated
inflammatory cell
inflammatory cells
investigated
knowledge
lead
longitudinal
majority
Mild
moderate
Neutralizing antibodies
neutralizing antibody
Novel coronavirus
onset of symptoms
Pairwise comparison
Patient
patients with COVID-19
plasma sample
plasma samples
populations
Profiling
RBD
reached
Real-time PCR
respiratory
response
S antigen
SARS-CoV-2
SARS-COV-2 infection
Seroconversion
serological test
Serological tests
Seroprevalence
severe acute respiratory syndrome Coronavirus
severe cases
Sex
significantly
specific antibodies
spike
Surveillance
Symptoms
Tertiary
the antibody response
the disease
undetectable
Vaccine
variety
Viral
Viral load
virus-specific antibodies
[DOI] 10.3389/fimmu.2021.614436 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.614436 PMC 바로가기 [Article Type] Immunology